2007年长江流域157家医院心脑血管类中成药的利用分析  

Utilization analysis of Chinese patent medicines on cardio-cerebral vascular in 157 hospitals of Yangtze River valley in 2007

作　　者：储秋萍[1] 冯琳[1] 戴惠珍[2] 陶琳[3] 

机构地区：[1]南京医科大学附属第一医院,江苏南京210029 [2]江苏省医药情报研究所,江苏南京210004 [3]上海市食品药品监督管理局科技情报研究所,上海200040

出　　处：《中国新药与临床杂志》2008年第10期775-780,共6页Chinese Journal of New Drugs and Clinical Remedies

摘　　要：目的评价长江流域6城市157家医院2007年心脑血管类中成药的应用状况。方法对入网医院临床应用的心脑血管类中成药的品种、用药金额和用药频度(DDDs)等信息按城市进行统计分析。结果2007年6城市心脑血管类中成药的用药总金额已达8.87亿元,较上年度增长了35.20%。在6城市通用名用药金额排名榜中,银杏、三七、疏血通排名榜首。在6城市品牌产品用药金额排名榜中,金水宝、疏血通、血栓通(冻干)位居前列;DDDs排名显示,银杏、复方丹参、珍菊降压片是长江流域心脑血管疾病防治中临床选用频率最高的品种。结论中成药已成为我国临床防治心脑血管疾病的重要手段,用药量逐年增长,应合理使用、加强研发。AIM To evaluate the utilization of Chinese patent medicines on cardio-cerebral vascular used in 157 hospitals of 6 cities in Yangtze River valley in 2007. METHODS Chinese patent medicines on cardio-cerebral vascular used in 157 hospitals were analyzed statistically in respect to the variety, consumption sum and Defined Daily Dose （DDDs） in each city. RESULTS The total annual cost of the Chinese patent medicines used in 6 cities was ￥ 887 million in 2007, increased 35.20 % compared to last year. In the column of consumption sum, Ginkgo biloba, Sanqi and Suxueton ranked high in general name. Jinshuibao, Suxueton, Xueshuanton （powder injection） ranked high in brand. The column of Fufangdansheng, Zhenjujianyapian were the most frequently used drugs DDDs indicated that to prevent and treat Ginkgo biloba, cardio-cerebral vascular diseases in the area. CONCLUSION The Chinese patent medicine has become an essential factor for the prevention and treatment of cardio-cerebral vascular diseases, and the consumption increase rapidly. Rational use and more research should be emphasized.

关 键 词：心血管药物 脑血管障碍 中成药 药物利用 经济学 药学 长江流域 

分 类 号：R971[医药卫生—药品] R972[医药卫生—药学]